← Back to Search

Algorithm

Advanced Algorithm-Controlled Prosthesis for Amputation

N/A
Recruiting
Led By Aaron Young, Ph.D.
Research Sponsored by Georgia Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will focus on new algorithms for powered prostheses and testing these in human subject tests. The study will compare the performance of the advanced algorithm with their take-home device, as well as with the robotic system that does not use an advanced algorithm.

Who is the study for?
This trial is for individuals aged 18 to 75 who have lost one leg above the knee and are able to walk on different surfaces. They must be fairly active (K3 or K4 level) and not pregnant, nor should they have any major muscle, nerve, or other health problems that would make it hard for them to use a robotic leg.Check my eligibility
What is being tested?
The study is testing new control algorithms in robotic prostheses designed for people with above-knee amputations. Participants will walk using these advanced robotic legs over simulated real-world terrain and their performance will be compared with standard non-advanced systems.See study design
What are the potential side effects?
While there aren't direct side effects like with medications, participants might experience discomfort while adjusting to the prosthesis or risk falling during tests due to unfamiliarity with the device's operation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Self-selected Walking Speed

Trial Design

1Treatment groups
Experimental Treatment
Group I: Smart Robotic Knee/Ankle ProthesisExperimental Treatment1 Intervention
This study will be conducted on a sample population of individuals with transfemoral amputation (single arm). Each participant will test with each condition of the study (repeated measures).

Find a Location

Who is running the clinical trial?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,963 Previous Clinical Trials
2,674,718 Total Patients Enrolled
Georgia Institute of TechnologyLead Sponsor
48 Previous Clinical Trials
5,524 Total Patients Enrolled
Aaron Young, Ph.D.Principal InvestigatorGeorgia Institute of Technology
3 Previous Clinical Trials
32 Total Patients Enrolled

Media Library

Advanced Algorithm for Prosthesis Control (Algorithm) Clinical Trial Eligibility Overview. Trial Name: NCT05537792 — N/A
Amputation Research Study Groups: Smart Robotic Knee/Ankle Prothesis
Amputation Clinical Trial 2023: Advanced Algorithm for Prosthesis Control Highlights & Side Effects. Trial Name: NCT05537792 — N/A
Advanced Algorithm for Prosthesis Control (Algorithm) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05537792 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment actively recruiting participants?

"The information posted on clinicaltrials.gov states that this medical trial is no longer seeking patients, as it last edited the listing in September of 2022. Despite this, 66 other trials are actively recruiting participants at present time."

Answered by AI

What parameters must a potential participant satisfy to be included in this experiment?

"Patients between 18 and 75, who have a unilateral transfemoral amputation of the lower limb, can be selected for this medical trial. Furthermore, those chosen must demonstrate K3 or K4 level ambulatory capabilities to complete all associated locomotor tasks (as evaluated by a physiatrist/prosthetist). A total of 10 people are being admitted into the study."

Answered by AI

Does the research study allow participants under 35 years of age to enroll?

"As per the requirements of this study, participants must be between 18 to 75 years of age."

Answered by AI
~7 spots leftby Apr 2027